Showing 1 to 9 of 9 results


Rise of Misinformation on Social Media Impacts Contraceptive Choices
A new trend on social media platforms like TikTok is spreading misinformation about hormonal contraception, causing concern among experts due to its potential impact on women's reproductive health and choices.
Rise of Misinformation on Social Media Impacts Contraceptive Choices
A new trend on social media platforms like TikTok is spreading misinformation about hormonal contraception, causing concern among experts due to its potential impact on women's reproductive health and choices.
Progress
20% Bias Score


Trump Administration Cuts to Title X Jeopardize Contraception Access
The Trump administration is restricting access to contraception for low-income Americans by cutting Title X funding, impacting over 800,000 people and forcing organizations to rely on donations or close clinics, while state-level efforts further limit birth control access, potentially aligning with ...
Trump Administration Cuts to Title X Jeopardize Contraception Access
The Trump administration is restricting access to contraception for low-income Americans by cutting Title X funding, impacting over 800,000 people and forcing organizations to rely on donations or close clinics, while state-level efforts further limit birth control access, potentially aligning with ...
Progress
56% Bias Score


Essure Birth Control Device Faces 27,000 Complaints, FDA Scrutiny
The Essure permanent birth control device, despite FDA approval, has prompted nearly 27,000 complaints since 2002 due to reported severe side effects like pain and organ perforation, leading to sales restrictions, a black box warning, and a mandated FDA post-market trial concluding in 2023.
Essure Birth Control Device Faces 27,000 Complaints, FDA Scrutiny
The Essure permanent birth control device, despite FDA approval, has prompted nearly 27,000 complaints since 2002 due to reported severe side effects like pain and organ perforation, leading to sales restrictions, a black box warning, and a mandated FDA post-market trial concluding in 2023.
Progress
60% Bias Score


Lawsuits Target Pfizer's Depo-Provera Over Brain Tumor Risk
Hundreds of women are suing Pfizer, alleging its Depo-Provera birth control shot increased their risk of meningiomas, a type of brain tumor, resulting in life-altering symptoms; a study showed a 5.6-fold increased risk with prolonged use and the drug's US label lacks this warning unlike in Canada.
Lawsuits Target Pfizer's Depo-Provera Over Brain Tumor Risk
Hundreds of women are suing Pfizer, alleging its Depo-Provera birth control shot increased their risk of meningiomas, a type of brain tumor, resulting in life-altering symptoms; a study showed a 5.6-fold increased risk with prolonged use and the drug's US label lacks this warning unlike in Canada.
Progress
52% Bias Score


US Family Planning Access Plummets to 35.7%, Exposing Racial and Economic Disparities
A CDC report reveals that only 35.7% of women of reproductive age in the US received family planning services in 2022-2023, highlighting vast inequities by race and income and the impact of abortion restrictions on access to birth control.
US Family Planning Access Plummets to 35.7%, Exposing Racial and Economic Disparities
A CDC report reveals that only 35.7% of women of reproductive age in the US received family planning services in 2022-2023, highlighting vast inequities by race and income and the impact of abortion restrictions on access to birth control.
Progress
44% Bias Score

The Pill: Benefits, Risks, and Neurological Effects
This article examines the contraceptive pill's mechanism, benefits (reduced menstrual symptoms, improved skin, migraine relief, and lower cancer risk), risks (slightly increased thrombosis risk and potential mood changes), and ongoing neurological research into its brain effects.

The Pill: Benefits, Risks, and Neurological Effects
This article examines the contraceptive pill's mechanism, benefits (reduced menstrual symptoms, improved skin, migraine relief, and lower cancer risk), risks (slightly increased thrombosis risk and potential mood changes), and ongoing neurological research into its brain effects.
Progress
20% Bias Score

US Birth Control Access Varies Widely by State
A new report reveals that only one-third of US states ensure affordable birth control access through Medicaid expansion and insurer coverage, creating a two-tiered system impacting low-income individuals and minors.

US Birth Control Access Varies Widely by State
A new report reveals that only one-third of US states ensure affordable birth control access through Medicaid expansion and insurer coverage, creating a two-tiered system impacting low-income individuals and minors.
Progress
44% Bias Score

UK: Pregnancy Risk Linked to Weight-Loss Drugs and Birth Control Pills
In the UK, 40 women became pregnant while taking birth control pills and weight-loss drugs (Mounjaro, Saxenda, Ozempic/Wegovy); the MHRA warns of a potential link, advising against relying solely on oral contraceptives when using these drugs.

UK: Pregnancy Risk Linked to Weight-Loss Drugs and Birth Control Pills
In the UK, 40 women became pregnant while taking birth control pills and weight-loss drugs (Mounjaro, Saxenda, Ozempic/Wegovy); the MHRA warns of a potential link, advising against relying solely on oral contraceptives when using these drugs.
Progress
64% Bias Score

Women Ditch Pill for Fertility Apps: Challenges and Risks
A BBC report reveals women's struggles with hormonal contraception leading some to use fertility tracking apps, despite the higher risk of unintended pregnancies; this highlights the need for better contraceptive choices and support.

Women Ditch Pill for Fertility Apps: Challenges and Risks
A BBC report reveals women's struggles with hormonal contraception leading some to use fertility tracking apps, despite the higher risk of unintended pregnancies; this highlights the need for better contraceptive choices and support.
Progress
52% Bias Score
Showing 1 to 9 of 9 results